Heartflow Inc (HTFL) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

HTFL ranks #3051 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

HTFL is a top-conviction position for Bain Capital Life Sciences Investors, LLC — at 14.7% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Invesco Ltd. has added to its HTFL position for two straight quarters, increasing it by $50.6M to reach $67.4M today.

Bain Capital Life Sciences Investors, LLC has trimmed its HTFL position for two straight quarters, cutting it by $115.0M while still holding $247.9M.

HTFL is down 0.7% today, but institutions show net buying of $396.6M this quarter — a divergence between today's price move and the underlying institutional flow.

HTFL reported a net loss of $118.4M over the trailing twelve months.

• Not yet profitable — net loss of $118.4M over the trailing twelve months
• Revenue grew 42.8% year over year
• Net income declined year over year, from -$93.7M to -$118.4M
• Operating cash flow was negative, using $54.0M in cash
• Current ratio of 5.20x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.20x equity — within a conventional range